Study of Radiation Fractionation on Patient Outcomes After Breast REConstruction (FABREC) for Invasive Breast Carcinoma
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03422003 |
Recruitment Status :
Active, not recruiting
First Posted : February 5, 2018
Last Update Posted : November 22, 2023
|
Sponsor:
Dana-Farber Cancer Institute
Collaborator:
Patient-Centered Outcomes Research Institute
Information provided by (Responsible Party):
Rinaa Punglia, MD, MPH, Dana-Farber Cancer Institute
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Active, not recruiting |
---|---|
Actual Primary Completion Date : | October 31, 2023 |
Estimated Study Completion Date : | April 1, 2030 |
Publications: